{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:00:24Z","timestamp":1791914424551,"version":"4.3.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG019771"],"award-info":[{"award-number":["R01 AG019771"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AG072976"],"award-info":[{"award-number":["P30 AG072976"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AG024904"],"award-info":[{"award-number":["U19 AG024904"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG057739"],"award-info":[{"award-number":["R01 AG057739"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AG061796"],"award-info":[{"award-number":["R01-AG061796"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["U19-AG074879"],"award-info":[{"award-number":["U19-AG074879"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS080820"],"award-info":[{"award-number":["R01-NS080820"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer&apos;s Association","doi-asserted-by":"publisher","award":["Alzheimer\u2019s Association Zenith Fellows Award"],"award-info":[{"award-number":["Alzheimer\u2019s Association Zenith Fellows Award"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Determining the genetic architecture of Alzheimer\u2019s disease pathologies can enhance mechanistic understanding and inform precision medicine strategies. Here, we perform a genome-wide association study of cortical tau quantified by positron emission tomography in 3046 participants from 12 independent studies. The <jats:italic>CYP1B1<\/jats:italic>-<jats:italic>RMDN2<\/jats:italic> locus is associated with tau deposition. The most significant signal is at rs2113389, explaining 4.3% of the variation in cortical tau, while <jats:italic>APOE4<\/jats:italic> rs429358 accounts for 3.6%. rs2113389 is associated with higher tau and faster cognitive decline. Additive effects, but no interactions, are observed between rs2113389 and diagnosis, APOE4, and amyloid beta positivity. <jats:italic>CYP1B1<\/jats:italic> expression is upregulated in AD. rs2113389 is associated with higher <jats:italic>CYP1B1<\/jats:italic> expression and methylation levels. Mouse model studies provide additional functional evidence for a relationship between <jats:italic>CYP1B1<\/jats:italic> and tau deposition but not amyloid beta. These results provide insight into the genetic basis of cerebral tau deposition and support novel pathways for therapeutic development in AD.<\/jats:p>","DOI":"10.1038\/s41467-024-52298-2","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T12:02:59Z","timestamp":1726833779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["CYP1B1-RMDN2 Alzheimer\u2019s disease endophenotype locus identified for cerebral tau PET"],"prefix":"10.1038","volume":"15","author":[{"given":"Kwangsik","family":"Nho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3304-7943","authenticated-orcid":false,"given":"Shannon L.","family":"Risacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana G.","family":"Apostolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5357-9966","authenticated-orcid":false,"given":"Paula J.","family":"Bice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6578-0584","authenticated-orcid":false,"given":"Jared R.","family":"Brosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Deardorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3224-2736","authenticated-orcid":false,"given":"Kelley","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7897-5471","authenticated-orcid":false,"given":"Martin R.","family":"Farlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5549-2212","authenticated-orcid":false,"given":"Tatiana","family":"Foroud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7025-0222","authenticated-orcid":false,"given":"Thea","family":"Rosewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4376-3107","authenticated-orcid":false,"given":"Jun Pyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4040-1717","authenticated-orcid":false,"given":"Kelly","family":"Nudelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4551-0269","authenticated-orcid":false,"given":"Meichen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Aisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1535-6133","authenticated-orcid":false,"given":"Reisa","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basavaraj","family":"Hooli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Shcherbinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Svaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-622X","authenticated-orcid":false,"suffix":"Jr.","given":"Clifford R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4458-113X","authenticated-orcid":false,"given":"William J.","family":"Jagust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3857-8812","authenticated-orcid":false,"given":"Aparna","family":"Vasanthakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey F.","family":"Waring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8051-0558","authenticated-orcid":false,"given":"Vincent","family":"Dor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4355-7082","authenticated-orcid":false,"given":"Simon M.","family":"Laws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7887-6622","authenticated-orcid":false,"given":"Tenielle","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3910-2453","authenticated-orcid":false,"given":"Christopher C.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Villemagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"Dumitrescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3377-7014","authenticated-orcid":false,"given":"Timothy J.","family":"Hohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia B.","family":"Libby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Mormino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5356-5537","authenticated-orcid":false,"given":"Rachel F.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8318-0443","authenticated-orcid":false,"given":"Hyun-Sik","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8178-6601","authenticated-orcid":false,"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6591-8734","authenticated-orcid":false,"given":"Vijay K.","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4436-8889","authenticated-orcid":false,"given":"Nil\u00fcfer","family":"Ertekin-Taner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4286-0589","authenticated-orcid":false,"given":"Prashanthi","family":"Vemuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Hsien","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3453-1438","authenticated-orcid":false,"given":"M. Ilyas","family":"Kamboh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8546-8256","authenticated-orcid":false,"given":"Oscar L.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-6631","authenticated-orcid":false,"given":"Muhammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammie","family":"Benzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0276-2899","authenticated-orcid":false,"given":"Carlos","family":"Cruchaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7822-6411","authenticated-orcid":false,"given":"Diana","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8057-2505","authenticated-orcid":false,"given":"Philip L.","family":"De Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1227-9996","authenticated-orcid":false,"given":"Vaishnavi","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8507-2561","authenticated-orcid":false,"given":"Bruce T.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6400-544X","authenticated-orcid":false,"given":"Andy P.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1413-626X","authenticated-orcid":false,"given":"Isabel","family":"Castanho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1115-3224","authenticated-orcid":false,"given":"Jonathan","family":"Mill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Department of Defense Alzheimer\u2019s Disease Neuroimaging Initiative (DoD-ADNI)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Anti-Amyloid Treatment in Asymptomatic Alzheimer\u2019s Study (A4 Study) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Australian Imaging, Biomarker & Lifestyle Study (AIBL)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1376-8532","authenticated-orcid":false,"given":"Andrew J.","family":"Saykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"52298_CR1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","volume":"15","author":"Association, A. s. 2019.","year":"2019","unstructured":"Association, A. s. 2019. Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s & Dementia 15, 321\u2013387 (2019).","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"52298_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack Jr.","year":"2016","unstructured":"Jack, C. R. Jr. et al. A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87, 539\u2013547 (2016).","journal-title":"Neurology"},{"key":"52298_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gim.2015.117","volume":"18","author":"C Van Cauwenberghe","year":"2016","unstructured":"Van Cauwenberghe, C., Van Broeckhoven, C. & Sleegers, K. The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med 18, 421\u2013430 (2016).","journal-title":"Genet Med"},{"key":"52298_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet 51, 414\u2013430 (2019).","journal-title":"Nat Genet"},{"key":"52298_CR5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41588-018-0333-3","volume":"51","author":"PR Jansen","year":"2019","unstructured":"Jansen, P. R. et al. Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways. Nat Genet 51, 394\u2013403 (2019).","journal-title":"Nat Genet"},{"key":"52298_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9, 106\u2013118 (2013).","journal-title":"Nat Rev Neurol"},{"key":"52298_CR7","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jalz.2015.05.009","volume":"11","author":"AJ Saykin","year":"2015","unstructured":"Saykin, A. J. et al. Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans. Alzheimers Dement 11, 792\u2013814 (2015).","journal-title":"Alzheimers Dement"},{"key":"52298_CR8","volume":"2015","author":"J Li","year":"2015","unstructured":"Li, J. et al. Genetic interactions explain variance in cingulate amyloid burden: an AV-45 PET genome-wide association and interaction study in the ADNI cohort. Biomed Res Int 2015, 647389 (2015).","journal-title":"Biomed Res Int"},{"key":"52298_CR9","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1093\/brain\/awv231","volume":"138","author":"VK Ramanan","year":"2015","unstructured":"Ramanan, V. K. et al. GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer\u2019s disease implicates microglial activation gene IL1RAP. Brain: a journal of neurology 138, 3076\u20133088 (2015).","journal-title":"Brain: a journal of neurology"},{"key":"52298_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/mp.2013.19","volume":"19","author":"VK Ramanan","year":"2014","unstructured":"Ramanan, V. K. et al. APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study. Mol Psychiatry 19, 351\u2013357 (2014).","journal-title":"Mol Psychiatry"},{"key":"52298_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53604-5","volume":"9","author":"M Vacher","year":"2019","unstructured":"Vacher, M. et al. Validation of a priori candidate Alzheimer\u2019s disease SNPs with brain amyloid-beta deposition. Sci Rep 9, 17069 (2019).","journal-title":"Sci Rep"},{"key":"52298_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41380-018-0246-7","volume":"26","author":"Q Yan","year":"2021","unstructured":"Yan, Q. et al. Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging. Mol Psychiatry 26, 309\u2013321 (2021).","journal-title":"Mol Psychiatry"},{"key":"52298_CR13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3233\/JAD-151005","volume":"52","author":"QF Zhao","year":"2016","unstructured":"Zhao, Q. F. et al. ABCA7 genotypes confer Alzheimer\u2019s disease risk by modulating amyloid-beta pathology. J Alzheimers Dis 52, 693\u2013703 (2016).","journal-title":"J Alzheimers Dis"},{"key":"52298_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00401-017-1685-y","volume":"133","author":"Y Deming","year":"2017","unstructured":"Deming, Y. et al. Genome-wide association study identifies four novel loci associated with Alzheimer\u2019s endophenotypes and disease modifiers. Acta Neuropathol 133, 839\u2013856 (2017).","journal-title":"Acta Neuropathol"},{"key":"52298_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09564-5","volume":"10","author":"N Franzmeier","year":"2019","unstructured":"Franzmeier, N., Rubinski, A., Neitzel, J., Ewers, M. & Alzheimer\u2019s Disease Neuroimaging, I. The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory. Nat Commun 10, 1766 (2019).","journal-title":"Nat Commun"},{"key":"52298_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00401-022-02419-2","volume":"143","author":"VK Ramanan","year":"2022","unstructured":"Ramanan, V. K. et al. Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer\u2019s disease. Acta Neuropathol 143, 571\u2013583 (2022).","journal-title":"Acta Neuropathol"},{"key":"52298_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa159","volume":"2","author":"VK Ramanan","year":"2020","unstructured":"Ramanan, V. K. et al. Variants in PPP2R2B and IGF2BP3 are associated with higher tau deposition. Brain Commun 2, fcaa159 (2020).","journal-title":"Brain Commun"},{"key":"52298_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2022.09.002","volume":"120","author":"Y Guo","year":"2022","unstructured":"Guo, Y. et al. Genome-wide association study of brain tau deposition as measured by (18)F-flortaucipir positron emission tomography imaging. Neurobiol Aging 120, 128\u2013136 (2022).","journal-title":"Neurobiol Aging"},{"key":"52298_CR19","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/j.neurobiolaging.2015.03.002","volume":"36","author":"Y Komuro","year":"2015","unstructured":"Komuro, Y., Xu, G., Bhaskar, K. & Lamb, B. T. Human tau expression reduces adult neurogenesis in a mouse model of tauopathy. Neurobiol Aging 36, 2034\u20132042 (2015).","journal-title":"Neurobiol Aging"},{"key":"52298_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","volume":"12","author":"SM Bemiller","year":"2017","unstructured":"Bemiller, S. M. et al. TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy. Mol Neurodegener 12, 74 (2017).","journal-title":"Mol Neurodegener"},{"key":"52298_CR21","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.celrep.2020.01.063","volume":"30","author":"I Castanho","year":"2020","unstructured":"Castanho, I. et al. Transcriptional signatures of tau and amyloid neuropathology. Cell Rep 30, 2040\u20132054.e2045 (2020).","journal-title":"Cell Rep"},{"key":"52298_CR22","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-022-02454-z","volume":"144","author":"IE Jansen","year":"2022","unstructured":"Jansen, I. E. et al. Genome-wide meta-analysis for Alzheimer\u2019s disease cerebrospinal fluid biomarkers. Acta Neuropathol 144, 821\u2013842 (2022).","journal-title":"Acta Neuropathol"},{"key":"52298_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2016.89","volume":"3","author":"M Allen","year":"2016","unstructured":"Allen, M. et al. Human whole genome genotype and transcriptome data for Alzheimer\u2019s and other neurodegenerative diseases. Sci Data 3, 160089 (2016).","journal-title":"Sci Data"},{"key":"52298_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.185","volume":"5","author":"M Wang","year":"2018","unstructured":"Wang, M. et al. The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer\u2019s disease. Sci Data 5, 180185 (2018).","journal-title":"Sci Data"},{"key":"52298_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.142","volume":"5","author":"PL De Jager","year":"2018","unstructured":"De Jager, P. L. et al. A multi-omic atlas of the human frontal cortex for aging and Alzheimer\u2019s disease research. Sci Data 5, 180142 (2018).","journal-title":"Sci Data"},{"key":"52298_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107908","volume":"32","author":"YW Wan","year":"2020","unstructured":"Wan, Y. W. et al. Meta-analysis of the Alzheimer\u2019s disease human brain transcriptome and functional dissection in mouse models. Cell Rep 32, 107908 (2020).","journal-title":"Cell Rep"},{"key":"52298_CR27","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41588-024-01685-y","volume":"56","author":"M Fujita","year":"2024","unstructured":"Fujita, M. et al. Cell subtype-specific effects of genetic variation in the Alzheimer\u2019s disease brain. Nat Genet 56, 605\u2013614 (2024).","journal-title":"Nat Genet"},{"key":"52298_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00864-y","volume":"12","author":"A Vasanthakumar","year":"2020","unstructured":"Vasanthakumar, A. et al. Harnessing peripheral DNA methylation differences in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease. Clin Epigenetics 12, 84 (2020).","journal-title":"Clin Epigenetics"},{"key":"52298_CR29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet 51, 404\u2013413 (2019).","journal-title":"Nat Genet"},{"key":"52298_CR30","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","volume":"53","author":"DP Wightman","year":"2021","unstructured":"Wightman, D. P. et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat Genet 53, 1276\u20131282 (2021).","journal-title":"Nat Genet"},{"key":"52298_CR31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet 54, 412\u2013436 (2022).","journal-title":"Nat Genet"},{"key":"52298_CR32","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.tips.2011.08.005","volume":"32","author":"CS Ferguson","year":"2011","unstructured":"Ferguson, C. S. & Tyndale, R. F. Cytochrome P450 enzymes in the brain: emerging evidence of biological significance. Trends Pharmacol Sci 32, 708\u2013714 (2011).","journal-title":"Trends Pharmacol Sci"},{"key":"52298_CR33","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.drudis.2016.06.004","volume":"21","author":"C Ghosh","year":"2016","unstructured":"Ghosh, C. et al. Pathophysiological implications of neurovascular P450 in brain disorders. Drug Discov Today 21, 1609\u20131619 (2016).","journal-title":"Drug Discov Today"},{"key":"52298_CR34","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/j.1528-1167.2009.02428.x","volume":"51","author":"C Ghosh","year":"2010","unstructured":"Ghosh, C. et al. Pattern of P450 expression at the human blood-brain barrier: roles of epileptic condition and laminar flow. Epilepsia 51, 1408\u20131417 (2010).","journal-title":"Epilepsia"},{"key":"52298_CR35","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000216","volume":"4","author":"AL Benedet","year":"2018","unstructured":"Benedet, A. L. et al. CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem. Neurol Genet 4, e216 (2018).","journal-title":"Neurol Genet"},{"key":"52298_CR36","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1503\/jpn.120133","volume":"38","author":"S Miksys","year":"2013","unstructured":"Miksys, S. & Tyndale, R. F. Cytochrome P450-mediated drug metabolism in the brain. J Psychiatry Neurosci 38, 152\u2013163 (2013).","journal-title":"J Psychiatry Neurosci"},{"key":"52298_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.prostaglandins.2009.06.004","volume":"91","author":"JJ Iliff","year":"2010","unstructured":"Iliff, J. J. et al. Epoxyeicosanoid signaling in CNS function and disease. Prostaglandins Other Lipid Mediat 91, 68\u201384 (2010).","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"52298_CR38","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/mp.2012.42","volume":"18","author":"JC Stingl","year":"2013","unstructured":"Stingl, J. C., Brockmoller, J. & Viviani, R. Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function. Mol Psychiatry 18, 273\u2013287 (2013).","journal-title":"Mol Psychiatry"},{"key":"52298_CR39","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3233\/JAD-2011-110860","volume":"28","author":"C Chace","year":"2012","unstructured":"Chace, C. et al. Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer\u2019s disease in women with down syndrome. J Alzheimers Dis 28, 601\u2013612 (2012).","journal-title":"J Alzheimers Dis"},{"key":"52298_CR40","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1093\/brain\/awv166","volume":"138","author":"F Djelti","year":"2015","unstructured":"Djelti, F. et al. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer\u2019s disease. Brain: a journal of neurology 138, 2383\u20132398 (2015).","journal-title":"Brain: a journal of neurology"},{"key":"52298_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/nan.12058","volume":"40","author":"I Kapas","year":"2014","unstructured":"Kapas, I. et al. Cerebrotendinous xanthomatosis with the c.379C>T (p.R127W) mutation in the CYP27A1 gene associated with premature age-associated limbic tauopathy. Neuropathol Appl Neurobiol 40, 345\u2013350 (2014).","journal-title":"Neuropathol Appl Neurobiol"},{"key":"52298_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.1471-4159.2001.00379.x","volume":"78","author":"MA Pappolla","year":"2001","unstructured":"Pappolla, M. A. et al. Induction of NADPH cytochrome P450 reductase by the Alzheimer beta-protein. Amyloid as a \u201cforeign body\u201d. J Neurochem 78, 121\u2013128 (2001).","journal-title":"J Neurochem"},{"key":"52298_CR43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1046\/j.0022-3042.2001.00724.x","volume":"80","author":"PJ Van Ess","year":"2002","unstructured":"Van Ess, P. J., Pedersen, W. A., Culmsee, C., Mattson, M. P. & Blouin, R. A. Elevated hepatic and depressed renal cytochrome P450 activity in the Tg2576 transgenic mouse model of Alzheimer\u2019s disease. J Neurochem 80, 571\u2013578 (2002).","journal-title":"J Neurochem"},{"key":"52298_CR44","doi-asserted-by":"publisher","first-page":"21050","DOI":"10.1039\/C9RA03674A","volume":"9","author":"BR Shah","year":"2019","unstructured":"Shah, B. R., Xu, W. & Mraz, J. Cytochrome P450 1B1: role in health and disease and effect of nutrition on its expression. Rsc Adv 9, 21050\u201321062 (2019).","journal-title":"Rsc Adv"},{"key":"52298_CR45","first-page":"27","volume":"13","author":"J Falero-Perez","year":"2018","unstructured":"Falero-Perez, J., Song, Y. S., Sorenson, C. M. & Sheibani, N. CYP1B1: A key regulator of redox homeostasis. Trends Cell Mol Biol 13, 27\u201345 (2018).","journal-title":"Trends Cell Mol Biol"},{"key":"52298_CR46","doi-asserted-by":"publisher","first-page":"e0206756","DOI":"10.1371\/journal.pone.0206756","volume":"13","author":"J Falero-Perez","year":"2018","unstructured":"Falero-Perez, J. et al. Cyp1b1 expression impacts the angiogenic and inflammatory properties of liver sinusoidal endothelial cells. PLoS One 13, e0206756 (2018).","journal-title":"PLoS One"},{"key":"52298_CR47","doi-asserted-by":"publisher","first-page":"C1170","DOI":"10.1152\/ajpcell.00139.2013","volume":"305","author":"TL Palenski","year":"2013","unstructured":"Palenski, T. L., Gurel, Z., Sorenson, C. M., Hankenson, K. D. & Sheibani, N. Cyp1B1 expression promotes angiogenesis by suppressing NF-kappaB activity. Am J Physiol Cell Physiol 305, C1170\u2013C1184 (2013).","journal-title":"Am J Physiol Cell Physiol"},{"key":"52298_CR48","first-page":"7689","volume":"63","author":"F Chen","year":"2003","unstructured":"Chen, F., Castranova, V., Li, Z., Karin, M. & Shi, X. Inhibitor of nuclear factor kappaB kinase deficiency enhances oxidative stress and prolongs c-Jun NH2-terminal kinase activation induced by arsenic. Cancer Res. 63, 7689\u20137693 (2003).","journal-title":"Cancer Res"},{"key":"52298_CR49","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1182\/blood-2008-03-145219","volume":"113","author":"Y Tang","year":"2009","unstructured":"Tang, Y. et al. CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression. Blood 113, 744\u2013754 (2009).","journal-title":"Blood"},{"key":"52298_CR50","first-page":"2194","volume":"11","author":"Z Yang","year":"2019","unstructured":"Yang, Z. et al. CYP1B1 deiciency ameliorates learning and memory deficits caused by high fat diet in mice. Am J Transl Res. 11, 2194\u20132206 (2019).","journal-title":"Am J Transl Res"},{"key":"52298_CR51","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1001\/archneur.56.12.1449","volume":"56","author":"WR Markesbery","year":"1999","unstructured":"Markesbery, W. R. The role of oxidative stress in Alzheimer disease. Arch Neurol 56, 1449\u20131452 (1999).","journal-title":"Arch Neurol"},{"key":"52298_CR52","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/940603","volume":"2013","author":"S Mondragon-Rodriguez","year":"2013","unstructured":"Mondragon-Rodriguez, S. et al. Phosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: implications for Alzheimer\u2019s disease. Oxid Med Cell Longev 2013, 940603 (2013).","journal-title":"Oxid Med Cell Longev"},{"key":"52298_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/352723","volume":"2015","author":"Z Liu","year":"2015","unstructured":"Liu, Z. et al. The ambiguous relationship of oxidative stress, tau hyperphosphorylation, and autophagy dysfunction in Alzheimer\u2019s disease. Oxid Med Cell Longev 2015, 352723 (2015).","journal-title":"Oxid Med Cell Longev"},{"key":"52298_CR54","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 45, 1452\u20131458 (2013).","journal-title":"Nat Genet"},{"key":"52298_CR55","doi-asserted-by":"publisher","first-page":"e1002272","DOI":"10.1371\/journal.pmed.1002272","volume":"14","author":"NZ Steele","year":"2017","unstructured":"Steele, N. Z. et al. Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case-control study. PLoS Med 14, e1002272 (2017).","journal-title":"PLoS Med"},{"key":"52298_CR56","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.brainres.2008.02.084","volume":"1214","author":"A Sasaki","year":"2008","unstructured":"Sasaki, A. et al. Microglial activation in brain lesions with tau deposits: comparison of human tauopathies and tau transgenic mice TgTauP301L. Brain Res. 1214, 159\u2013168 (2008).","journal-title":"Brain Res"},{"key":"52298_CR57","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","volume":"68","author":"SW Scheff","year":"2007","unstructured":"Scheff, S. W., Price, D. A., Schmitt, F. A., DeKosky, S. T. & Mufson, E. J. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68, 1501\u20131508 (2007).","journal-title":"Neurology"},{"key":"52298_CR58","doi-asserted-by":"publisher","first-page":"10741","DOI":"10.1523\/JNEUROSCI.1065-09.2009","volume":"29","author":"M Polydoro","year":"2009","unstructured":"Polydoro, M., Acker, C. M., Duff, K., Castillo, P. E. & Davies, P. Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. J Neurosci 29, 10741\u201310749 (2009).","journal-title":"J Neurosci"},{"key":"52298_CR59","doi-asserted-by":"publisher","first-page":"E3773","DOI":"10.1073\/pnas.1604519113","volume":"113","author":"Y Yin","year":"2016","unstructured":"Yin, Y. et al. Tau accumulation induces synaptic impairment and memory deficit by calcineurin-mediated inactivation of nuclear CaMKIV\/CREB signaling. Proc Natl Acad Sci USA 113, E3773\u2013E3781 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"52298_CR60","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover, B. R. et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68, 1067\u20131081 (2010).","journal-title":"Neuron"},{"key":"52298_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15295","volume":"8","author":"L Zhou","year":"2017","unstructured":"Zhou, L. et al. Tau association with synaptic vesicles causes presynaptic dysfunction. Nat Commun 8, 15295 (2017).","journal-title":"Nat Commun"},{"key":"52298_CR62","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2217\/nmt.15.36","volume":"5","author":"E Popugaeva","year":"2015","unstructured":"Popugaeva, E., Vlasova, O. L. & Bezprozvanny, I. Restoring calcium homeostasis to treat Alzheimer\u2019s disease: a future perspective. Neurodegener Dis Manag 5, 395\u2013398 (2015).","journal-title":"Neurodegener Dis Manag"},{"key":"52298_CR63","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40478-016-0299-2","volume":"4","author":"K Kurbatskaya","year":"2016","unstructured":"Kurbatskaya, K. et al. Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer\u2019s disease brain. Acta Neuropathol Commun 4, 34 (2016).","journal-title":"Acta Neuropathol Commun"},{"key":"52298_CR64","first-page":"137","volume":"7","author":"Y Tan","year":"2012","unstructured":"Tan, Y., Deng, Y. & Qing, H. Calcium channel blockers and Alzheimer\u2019s disease. Neural Regen Res. 7, 137\u2013140 (2012).","journal-title":"Neural Regen Res"},{"key":"52298_CR65","first-page":"124","volume":"2017","author":"Y Lee","year":"2018","unstructured":"Lee, Y. et al. Genetic variation affecting exon skipping contributes to brain structural atrophy in Alzheimer\u2019s disease. AMIA Jt Summits Transl Sci Proc 2017, 124\u2013131 (2018).","journal-title":"AMIA Jt Summits Transl Sci Proc"},{"key":"52298_CR66","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1212\/WNL.0b013e318204a397","volume":"76","author":"S Kim","year":"2011","unstructured":"Kim, S. et al. Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology 76, 69\u201379 (2011).","journal-title":"Neurology"},{"key":"52298_CR67","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng1847","volume":"38","author":"AL Price","year":"2006","unstructured":"Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38, 904\u2013909 (2006).","journal-title":"Nat Genet"},{"key":"52298_CR68","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/mp.2013.24","volume":"18","author":"K Nho","year":"2013","unstructured":"Nho, K. et al. Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Mol Psychiatry 18, 781\u2013787 (2013).","journal-title":"Mol Psychiatry"},{"key":"52298_CR69","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559\u2013575 (2007).","journal-title":"Am J Hum Genet"},{"key":"52298_CR70","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","volume":"26","author":"CJ Willer","year":"2010","unstructured":"Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190\u20132191 (2010).","journal-title":"Bioinformatics"},{"key":"52298_CR71","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajhg.2010.11.011","volume":"88","author":"J Yang","year":"2011","unstructured":"Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 88, 76\u201382 (2011).","journal-title":"Am J Hum Genet"},{"key":"52298_CR72","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1093\/nar\/gky175","volume":"46","author":"S Yoon","year":"2018","unstructured":"Yoon, S. et al. Efficient pathway enrichment and network analysis of GWAS summary data using GSA-SNP2. Nucleic Acids Res. 46, e60 (2018).","journal-title":"Nucleic Acids Res"},{"key":"52298_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50507-3","volume":"9","author":"E Horgusluoglu-Moloch","year":"2019","unstructured":"Horgusluoglu-Moloch, E. et al. Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways. Sci Rep 9, 14498 (2019).","journal-title":"Sci Rep"},{"key":"52298_CR74","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ajhg.2011.01.019","volume":"88","author":"MX Li","year":"2011","unstructured":"Li, M. X., Gui, H. S., Kwan, J. S. & Sham, P. C. GATES: a rapid and powerful gene-based association test using extended Simes procedure. Am J Hum Genet 88, 283\u2013293 (2011).","journal-title":"Am J Hum Genet"},{"key":"52298_CR75","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.dadm.2018.07.002","volume":"10","author":"LM Shaw","year":"2018","unstructured":"Shaw, L. M. et al. Derivation of cutoffs for the Elecsys(\u00ae) amyloid \u03b2 (1-42) assay in Alzheimer\u2019s disease. Alzheimers Dement (Amst) 10, 698\u2013705 (2018).","journal-title":"Alzheimers Dement (Amst)"},{"key":"52298_CR76","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","volume":"14","author":"O Hansson","year":"2018","unstructured":"Hansson, O. et al. CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u03b2 PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimers Dement 14, 1470\u20131481 (2018).","journal-title":"Alzheimers Dement"},{"key":"52298_CR77","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa, U. et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet 53, 1300\u20131310 (2021).","journal-title":"Nat Genet"},{"key":"52298_CR78","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.3233\/JAD-179939","volume":"64","author":"DA Bennett","year":"2018","unstructured":"Bennett, D. A. et al. Religious orders study and rush memory and aging project. J Alzheimers Dis 64, S161\u2013S189 (2018).","journal-title":"J Alzheimers Dis"},{"key":"52298_CR79","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nature11405","volume":"489","author":"MJ Hawrylycz","year":"2012","unstructured":"Hawrylycz, M. J. et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489, 391\u2013399 (2012).","journal-title":"Nature"},{"key":"52298_CR80","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/nn.4171","volume":"18","author":"M Hawrylycz","year":"2015","unstructured":"Hawrylycz, M. et al. Canonical genetic signatures of the adult human brain. Nat Neurosci 18, 1832\u20131844 (2015).","journal-title":"Nat Neurosci"},{"key":"52298_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2022.06.020","author":"JP Kim","year":"2022","unstructured":"Kim, J. P. et al. Integrative co-methylation network analysis identifies novel DNA methylation signatures and their target genes in Alzheimer\u2019s disease. Biol Psychiatry https:\/\/doi.org\/10.1016\/j.biopsych.2022.06.020 (2022).","journal-title":"Biol Psychiatry"},{"key":"52298_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01179-2","volume":"13","author":"QS Li","year":"2021","unstructured":"Li, Q. S. et al. Association of peripheral blood DNA methylation level with Alzheimer\u2019s disease progression. Clin Epigenetics 13, 191 (2021).","journal-title":"Clin Epigenetics"},{"key":"52298_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00409-0","volume":"15","author":"VS Jadhav","year":"2020","unstructured":"Jadhav, V. S. et al. Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice. Molecular Neurodegeneration 15, 62 (2020).","journal-title":"Molecular Neurodegeneration"},{"key":"52298_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01022-0","volume":"14","author":"AP Tsai","year":"2022","unstructured":"Tsai, A. P. et al. PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer\u2019s disease. Genome Medicine 14, 17 (2022).","journal-title":"Genome Medicine"},{"key":"52298_CR85","doi-asserted-by":"publisher","first-page":"10637","DOI":"10.1523\/JNEUROSCI.3279-05.2005","volume":"25","author":"M Ramsden","year":"2005","unstructured":"Ramsden, M. et al. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci 25, 10637\u201310647 (2005).","journal-title":"J Neurosci"},{"key":"52298_CR86","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.1113694","volume":"309","author":"K Santacruz","year":"2005","unstructured":"Santacruz, K. et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476\u2013481 (2005).","journal-title":"Science"},{"key":"52298_CR87","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","volume":"96","author":"AY Hsia","year":"1999","unstructured":"Hsia, A. Y. et al. Plaque-independent disruption of neural circuits in Alzheimer\u2019s disease mouse models. Proc Natl Acad Sci USA 96, 3228\u20133233 (1999).","journal-title":"Proc Natl Acad Sci USA"},{"key":"52298_CR88","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","volume":"20","author":"L Mucke","year":"2000","unstructured":"Mucke, L. et al. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20, 4050\u20134058 (2000).","journal-title":"J Neurosci"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52298-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52298-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52298-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T13:02:30Z","timestamp":1726837350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52298-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52298"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52298-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]},"assertion":[{"value":"14 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Apostolova received grant or other financial support from the National Institutes of Health (NIH), Alzheimer\u2019s Association, AVID Pharmaceuticals, Life Molecular Imaging, Roche Diagnostics, and Eli Lilly. In addition, she has received consulting fees from Biogen, Two Labs, IQIVA, Florida Department of Health, Genentech, NIH Biobank, Eli Lilly, GE Healthcare, Eisai, and Roche Diagnostics. She has also received payment or honoraria from American Academy of Neurology, MillerMed, National Alzheimer\u2019s Coordinating Center CME, CME Institute, APhA, Purdue University, Mayo Clinic, MJH Physician Education Resource, and Ohio State University. She received support for travel from the Alzheimer\u2019s Association. She has served on Data Safety and Monitoring or Advisory Boards for IQVIA, UAB Nathan Schock Center, New Mexico Exploratory ADRC, and NIA R01 AG061111. She has a leadership role in multiple committees, including the Medical Science Council of the Alzheimer\u2019s Association Greater Indiana Chapter, the Alzheimer\u2019s Association Science Program Committee, and the FDA PCNS Advisory Committee. Finally, Dr. Apostolova holds stock in Cassava Neurosciences and Golden Seeds. Dr. Foroud receives support from multiple NIH grants (U24 NS095871, U24 AG021886, U24 AG056270, U01 AA026103, U10 AA008401, P30 AG010133, R01 AG019771, U01 AG032984, P30 AR072581, U01 AG057195, UL1 TR002529, U19 AG063911; U19 AG063744, U19 AG068054, R01 AG069453, U54 CA196519, R01 AG061146, R01 AG073267, R01 AG074971, U19 AG071754, R01 AG055444, R01 AG070349, U19 AG024904, R01 AG076634, U19 AG079774, U54 CA280897, U19 NS120384); the Michael J. Fox Foundation (MJFF001948); Cohen Veterans Biosciences; The Parkinson\u2019s Disease Foundation; Children\u2019s Tumor Foundation; Broad Institute; Lumind Foundation; and Gates Venture (0432-06-120975). Dr. Jagust has served as a consultant for Biogen, Eisai, Lilly, and Bioclinica. He has an equity interest in Optoceuticals. Aparna Vasanthakumar and Jeffrey F. Waring are employees of AbbVie and may own AbbVie stock. Dr. Hohman receives support from multiple NIH grants (U24-AG074855, P20-AG068082, R01-AG061518, R01-AG059716, R01-AG074012, RF1-AG059869). He also sits on the advisory board for Vivid Genomics and is a Senior Associate Editor for Alzheimer\u2019s and Dementia: Translational Research and Clinical Intervention. Hyun-Sik Yang received personal fees (honorarium) from Genentech, Inc outside the submitted work. Dr. Vemuri receives funding support from the NIH. Dr. Cruchaga has received research support from: GSK and EISAI. The funders of the study had no role in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. Dr. Cruchaga is a member of the advisory board of Vivid Genomics and Circular Genomics. Dr. Saykin receives support from multiple NIH grants (P30 AG010133, P30 AG072976, R01 AG019771, R01 AG057739, U19 AG024904, R01 LM013463, R01 AG068193, T32 AG071444, U01 AG068057, U01 AG072177 and U19 AG074879). He has also received support from Avid Radiopharmaceuticals, a subsidiary of Eli Lilly (in kind contribution of PET tracer precursor); Bayer Oncology (Scientific Advisory Board); Eisai (Scientific Advisory Board); Siemens Medical Solutions USA, Inc. (Dementia Advisory Board); NIH NHLBI (MESA Observational Study Monitoring Board); Springer-Nature Publishing (Editorial Office Support as Editor-in-Chief, Brain Imaging and Behavior). Dr. Ertekin-Taner receives support from multiple NIH grants (R01 AG061796, U19 AG074879, U01 AG046139, KL2 TR002379), Alzheimer\u2019s Association Zenith Fellows Award and Florida Department of Health. She serves as an advisor to the Framingham Heart Study (NIH NHLBI 75N92019D00031\/75N92019F00125). She also has a provisional patent application unrelated to this work. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8251"}}